BSE: SANOFI - Sanofi India Limited

छह महीने के लिए लाभप्रदता: -13.79%
भाग प्रतिफल: +1.71%

पदोन्नति कार्यक्रम Sanofi India Limited

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में Sanofi India Limited

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors.

अधिक जानकारी
It also exports its products to approximately 35 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

ISIN INE058A01010
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 1.71
Дивиденд ао 68.21
Сайт https://www.sanofiindialtd.com
Цена ао 5991.15
प्रति दिन मूल्य परिवर्तन: -2.67% (5991.15)
प्रति सप्ताह मूल्य परिवर्तन: +2.25% (5702.95)
प्रति माह मूल्य परिवर्तन: +15.25% (5059.65)
3 महीने में कीमत में बदलाव: -4.34% (6095.85)
छह महीने में कीमत में बदलाव: -13.79% (6764.2)
प्रति वर्ष मूल्य परिवर्तन: -28.17% (8118.25)
3 वर्षों में मूल्य परिवर्तन: -20.58% (7341.85)
5 वर्षों में मूल्य परिवर्तन: -20.85% (7367.55)
वर्ष की शुरुआत से मूल्य परिवर्तन: -4.34% (6095.85)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 6.55 1
P/BV 18.17 1
P/E 30.59 5
EV/EBITDA 17.69 6
कुल: 4.63

क्षमता

नाम अर्थ श्रेणी
ROA, % 35.16 9
ROE, % 59.39 10
कुल: 5.83

लाभांश

नाम अर्थ श्रेणी
Div yield, % 1.71 4.28
DSI 0.8571 8.57
कुल: 5.02

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA 0.026 10
कुल: 10

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % -8.24 0
लाभप्रदता Ebitda, % 20.55 4
लाभप्रदता EPS, % 50.5 7
कुल: 3.4
अधिक जानकारी

ETF शेयर करना, % वर्ष के लिए लाभप्रदता, % लाभांश, %
iShares MSCI India Small-Cap ETF 0.16695 0.4625 0.96163
SPDR S&P Emerging Markets Small Cap ETF 0.07114 5.46 3.03583
iShares MSCI Emerging Markets Small-Cap ETF 0.04483 7.67 2.7853
Avantis Emerging Markets Value ETF 0.03441 14.12 4.22231
Avantis Responsible Emerging Markets Equity ETF 0.02777 17.6 3.1719
Vanguard FTSE All-World ex-US Small-Cap ETF 0.02 9.39 3.09932
Avantis Emerging Markets Equity ETF 0.01484 8.77 3.60513
Dimensional Emerging Markets Core Equity 2 ETF 0.0079 15.96 3.34087
Dimensional World ex U.S. Core Equity 2 ETF 0.00469 13.06 3.62488
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.00447 12.46 3.59676

पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Rodolfo Hrosz MD & Director 17.85M 1967 (58 साल)
Mr. M. K. Narayanaswamy B.Com.,A.I.C.W.A. Senior Director of Accounting & Taxation N/A 1955 (70 साल)
Mr. Sanjay V. Chavan Head of Country Procurement - India N/A 1962 (63 वर्ष)
Ms. Surabhi Kaur People & Culture Director N/A
Ms. Renee Amonkar Additional Whole Time Director N/A
Mr. Rachid Ayari CFO & Whole Time Director N/A
Ms. Flovie Martins Head of Corporate Communications & Corporate Social Responsibility
Nakul Verma Senior Director of Public Affairs
Yasmin Shenoy Senior Director of Regulatory Affairs
Mr. N. Suresh Babu Sales & Customer Engagement Head - Diabetes and Senior Director of Diabetes

पता: India, Mumbai, Sanofi House - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.sanofiindialtd.com